Perhaps it would be ideal if medical decision makers were driven by human factors rather than consequences, but that regretably is not the case. Screening recommendations by policy makers balance benefit and risk well but have a more difficult time balancing benefit – risk vs cost. What is the value of a woman surviving rather than dying prematurely from breast cancer? What is the cost of screening the x number of women in order to save one life?

When the american cancer society and most other medical organizations have gone through the gut wrenching process of making such difficult choices, surely whether the recommended policies should be followed, ought not depend upon the size of one cohones.